For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Applications
Trastuzumab Peptide Mapping with Tryptic Digest on bioZen 1.6 µm Peptide PS-C18
25055
Separation Mode: Reversed Phase
Reversed Phase
Peptide PS-C18
HPLC
Pharmaceutical/Biopharmaceutical
Therapeutic / Clinical
Therapeutic / Clinical
Therapeutic / Clinical

Trastuzumab Peptide Mapping with Tryptic Digest on bioZen 1.6 µm Peptide PS-C18

Analytes
1Tryptic Digest of Trastuzumab
Details
LC Conditions (App ID: 25055)
Column:
Brand Name:
bioZen
Part No:
Phase Name:
Peptide PS-C18
System:
Agilent Technologies 1290 Infinity Agilent Technologies 1290 Infinity
Sample Note:
1% acetonitrile, 0.1% formic acid in water
Similar Applications
search
No Data